Albuquerque, New Mexico 2021-06-11 16:37:07 –
This treatment is not a cure, but it is said to slow the progression of Alzheimer’s disease in people in the early stages of the disease.
“This is important because 60% of cases of Alzheimer’s disease are often unrecognized, and when people are diagnosed, the diagnosis is very slow,” Kenny said.
Tim Sheehan, executive director of the Alzheimer’s Association in New Mexico, said he was excited about the treatment.
“For those who are diagnosed early, it can give them a better time with their family and their caregivers. That’s all now,” Sheahan said.
Treatment comes with a high price tag of over $ 50,000. “We are fighting at the national level through Washington DC and other things, so we can get fairness for everyone. One of the things we think because this is not a low cost drug. That’s one, “says Sheahan.
It may take several weeks before people can get treatment. In the meantime, Sheehan said she should contact her doctor if she was interested in the drug.
It’s important to note, the drug is controversial. Some doctors disagree with the FDA’s approval, saying they will not prescribe treatment to their patients.
Three members of the FDA’s advisory board have resigned from drug approval. Some members of the panel said there was not enough evidence to prove that the drug was safe and effective.
FDA approves new controversial treatment for Alzheimer’s patients Source link FDA approves new controversial treatment for Alzheimer’s patients